Literature DB >> 31147090

Online information on oncologists' and non-medical practitioners' websites in Germany: A critical comparison.

Henriette Schallock1, Berit Bartmann2, Christian Keinki3, Jutta Huebner4.   

Abstract

OBJECTIVE: To survey websites of oncologists and non-medical practitioners (NMPs) in Germany regarding range of treated symptoms, diagnostic tools and therapies offered to cancer patients as well as the quality of websites.
METHODS: Analysis of 98 websites of oncologists and NMPs was conducted between April and July 2018 with a standardized tool.
RESULTS: Range of diagnostic and therapeutic methods was high and differed between both groups. Many NMPs (65.3%) intended to support conventional therapy rather than to treat cancer. Most oncologists (85.7%) did not mention the role of complementary and alternative medicine (CAM). Texts on oncologists' websites, showed high complexity according to readability analysis using LIX score as opposed to those on NMPs websites that showed medium complexity. Only small difference of quality of websites between both groups could be detected.
CONCLUSION: Methods not acknowledged by evidence-based medicine as well as methods at risk for interaction with conventional cancer therapy but also treatment offers with potential benefits for cancer patients were found on NMPs websites. PRACTICE IMPLICATIONS: As evidence-based CAM methods can be a useful support of cancer treatment, risk of herb drug interactions can be minimized by oncologists offering reasonable CAM.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Information; Non-medical practitioners; Oncologists; Readability; Website

Year:  2019        PMID: 31147090     DOI: 10.1016/j.pec.2019.05.022

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  1 in total

1.  Internet Information on Oral Cancer Drugs: a Critical Comparison between Website Providers.

Authors:  Berit Bartmann; Henriette Schallock; Clara Dubois; Christian Keinki; Bijan Zomorodbakhsch; Michael Hartmann; Jutta Hübner
Journal:  J Cancer Educ       Date:  2020-10-30       Impact factor: 1.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.